Andrew Mahan

Johnson & Johnson (United States)

Papers

1

Total Citations

24

H-Index

1

About

Andrew Mahan is a leading innovator in the field of automated bioanalytical chemistry, with a primary focus on developing high-throughput mass spectrometry systems for biotherapeutic characterization. His most impactful work, the 2023 paper "Lab of the Future─Today," has already garnered 24 citations and describes a fully integrated, multi-instrument robotic platform that revolutionizes the analysis of biotherapeutics. This system seamlessly combines liquid handling robotics, microplate automation, integrated liquid chromatography-mass spectrometry (LC-MS), and sophisticated data analysis software into a single, state-of-the-art workflow. Mahan’s major contribution lies in transforming the traditionally manual, time-intensive process of mass spectrometry characterization into a fully automated, high-throughput operation, dramatically increasing efficiency and reproducibility in biopharmaceutical development. His work represents a pivotal step toward the "lab of the future," where complex analytical tasks are executed with unprecedented speed and precision. By bridging the gap between robotics and advanced mass spectrometry, Andrew Mahan is setting new standards for how biotherapeutics are analyzed, directly impacting the speed and reliability of drug discovery and quality control in the pharmaceutical industry.

Research Focus

Key Achievements

1
H-Index
1
Papers
24
Total Citations
24
Avg Citations/Paper
🏆 Most Cited Paper
“Lab of the Future”─Today: Fully Automated System for High-Throughput Mass Spectrometry Analysis of Biotherapeutics
24 citations · 2023
📈 Most Prolific Year: 2023 (1 Papers)
🤝 Key Collaborators: 13
🏛 Institutions: Johnson & Johnson (United States)

Top Papers

  1. 1

Key Collaborators

Contact & Links

Available for collaboration
Content generated · 13 days ago